Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Oct. 1-10. Deal Watch is supported by deal intelligence from Strategic Transactions.
Takeda Pharmaceutical Co. Ltd. is laying the groundwork for new cancer developments with a pair of platform investments, with Australia's EnGeneIC Ltd. for a nanocell technology and with...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?